Tignanelli, ChristopherPuskarich, Michael2020-05-012020-05-012020-05-01https://hdl.handle.net/11299/212950Find and request access to full dataset at https://search.vivli.org/studyDetails/fromSearch/14656472-bbba-4b76-b155-8ae1f2d65694. A related dataset, "Randomized Controlled Trial of Losartan for Patients With COVID-19 Not Requiring Hospitalization," is also available through the Vivli repository at https://search.vivli.org/studyDetails/fromSearch/01206e7c-5516-4f0a-b891-f85a4075bc52.The University of Minnesota Medical School is currently performing clinical research trials to find treatments for the COVID-19. One of the studies examines a blood pressure medication, losartan, to see if it can help alleviate the severity of the disease. This is a multi-center (M Health Fairview and Hennepin County Medical Center), double-blinded study of COVID-19 infected patients who will be randomized 1:1 to daily losartan or placebo for 10 days or until hospital discharge.DatasetSee full Vivli data record for guidance on reuse of data.